retatrutide clinical trial results

retatrutide clinical trial results Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a Best Retatrutide Peptide (Triple Agonist)

Name: retatrutide clinical trial results Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a Best Retatrutide Peptide (Triple Agonist)
Brand: www.keygrove.com
SKU: 44270834037
Price: 29.11 USD
Availability: InStock
Rating: 4.1647 (26 reviews)

SKU: 44270834037

4.2

USD29.11 USD66.11

Pay in 4 interest-free payments of $7.28 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 13 - Aug 18

Description

GLP-1 drugs work by mimicking a hormone involved in blood-sugar regulation and may affect appetite and digestion

Published in the New England Journal of Medicine, the trial tested retatrutide at doses of 1mg, 4mg, 8mg, and 12mg against placebo over 48 weeks

How Do You Know When Semaglutide GLP-1 Is Working

GLP-1 GIP

For researchers tracking the retatrutide availability timeline, the compound is currently in multiple phase 3 trials with results expected throughout the coming period